Maryland Democrats Urge OMB to Rescind Rule Politicizing Federal Grant Decision-Making
treatment of diseases such as pediatric cancer and sickle cell disease and drive the development of new technologies
Search
Full-text search across every press release in the archive. Matches the title and body, with English stemming, “vote” catches “voted” and “voting.”
7 results for “sickle” · Maryland
Maryland Democrats Urge OMB to Rescind Rule Politicizing Federal Grant Decision-Making
treatment of diseases such as pediatric cancer and sickle cell disease and drive the development of new technologies … treatment of diseases such as pediatric cancer and sickle cell disease and drive the development of new technologies
Maryland Democrats Urge OMB to Rescind Rule Politicizing Federal Grant Decision-Making
treatment of diseases such as pediatric cancer and sickle cell disease and drive the development of new technologies … treatment of diseases such as pediatric cancer and sickle cell disease and drive the development of new technologies
Maryland Democrats Urge OMB to Rescind Rule Politicizing Federal Grant Decision-Making
treatment of diseases such as pediatric cancer and sickle cell disease and drive the development of new technologies … treatment of diseases such as pediatric cancer and sickle cell disease and drive the development of new technologies
Hoyer Opening Remarks at Full Committee Markup of FY26 Labor, Health and Human Services, Education, and Related Agencies Bill
cuts to research grants aimed at cutting sickle cell anemia? Was that based on scientific merit? Was Trump
Van Hollen Joins Booker, Davis in Introducing Bicameral World Sickle Cell Awareness Day Resolution
resolution to designate June 19, 2025 as “World Sickle Cell Awareness Day” to increase public awareness about sickle … will introduce companion legislation in the House. Sickle cell disease (SCD) is a rare, inherited disorder that causes
Van Hollen, Alsobrooks, and Maryland Democratic Delegation Fire Back at Trump’s Massive Cuts to Medical Research Funding in Maryland
pacemaker, and the first effective treatment for sickle cell anemia. JHU supports over 600 current and ongoing clinical